IP Library Granted Patent US 9,642,945
Granted Patent B2
US 9,642,945 · App. 15/298,478 · Granted May 9, 2017

Bioabsorbable polymeric composition for a medical device

Inventors: G. Lawrence Thatcher (Chelmsford, MA); Robert J. Cottone (Davie, FL)
Assignee: OrbusNeich Medical, Inc.
A61L31/14A61F2/915A61L31/06A61L31/148A61L31/16A61L31/18A61F2210/0004A61L2300/606
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,642,945
App. No.
15/298,478
Granted
May 9, 2017
Kind
B2
Abstract

A biodegradable and biocompatible nontoxic polymeric composition is provided which includes a base material such as a crystallizable polymer, copolymer, or terpolymer, and a copolymer or terpolymer additive. Medical devices manufactured from the composition are also provided.

Claims (10)

1. A bioabsorbable stent comprising a crystalline polymer composition, the polymer composition comprising, a poly (L-lactide) moiety, and/or a poly (D-lactide) moiety, and/or poly L-lactide-co-PEG moiety, and/or poly D-lactide-co-PEG moiety, linked or admixed with poly (L-lactide-co-Tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers or blocky random copolymers.

2. The stent of claim 1 , wherein the polymer composition comprises poly (L-lactide), linked or admixed with poly (L-lactide-co-ε-caprolactone) in the form of block copolymers or blocky random copolymers.

3. The stent of claim 1 , wherein the polymer composition is further crystallized upon expansion of the stent.

4. The stent of claim 1 , wherein the stent is balloon-expandable.

5. The stent of claim 1 , wherein the stein comprises a hoop structure.

6. The stent of claim 1 , further comprising at least one radiopaque marker.

7. The stent of claim 1 , further including, at least one pharmaceutical agent.

8. The stent of claim 1 , further including a barrier layer which contains at least one pharmaceutical agent.

9. The stent of claim 3 , wherein the polymer composition is crystallized in scaffold struts upon orthogonal strain deployment.

10. A bioabsorbable scaffold comprising a crystalline polymer composition, the polymer composition comprising, a poly (L-lactide) moiety, and/or a poly (D-lactide) moiety, and/or poly L-lactide-co-PEG moiety, and/or poly D-lactide-co-PEG moiety, linked or admixed with poly (L-lactide-co-Tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers or blocky random copolymers.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 15, 2022
From: ORBUSNEICH MEDICAL PTE. LTD.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 060386/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: ORBUSNEICH MEDICAL, INC.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 048043/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2017
From: THATCHER, G. LAWRENCE; COTTONE, ROBERT J.
To: ORBUSNEICH MEDICAL, INC.
Reel/Frame 041028/0847 →
Continuity (7)
Continuation 14542716 · Nov 17, 2014
Continuation 13370394 · Feb 10, 2012
Continuation 12508442 · Jul 23, 2009
Continuation 11781230 · Jul 20, 2007
Provisional Application 60807932 · Jul 20, 2006
Provisional Application 60862433 · Oct 20, 2006
Related Publication 20170035945A1 · Feb 9, 2017